Josep Lloreta

ORCID: 0000-0003-1644-9470
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bladder and Urothelial Cancer Treatments
  • Urinary and Genital Oncology Studies
  • Prostate Cancer Treatment and Research
  • Epigenetics and DNA Methylation
  • Prostate Cancer Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Genetic factors in colorectal cancer
  • Fibroblast Growth Factor Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Cancer Genomics and Diagnostics
  • Cancer, Lipids, and Metabolism
  • Urologic and reproductive health conditions
  • Renal cell carcinoma treatment
  • Metastasis and carcinoma case studies
  • Medical Imaging and Pathology Studies
  • Sarcoma Diagnosis and Treatment
  • Skin and Cellular Biology Research
  • Molecular Biology Techniques and Applications
  • Ferroptosis and cancer prognosis
  • Esophageal Cancer Research and Treatment
  • Soft tissue tumor case studies
  • Cancer Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Occupational and environmental lung diseases
  • Renal and related cancers

Universitat Pompeu Fabra
2012-2025

Hospital del Mar Research Institute
2014-2025

Hospital Del Mar
2010-2023

Memorial Sloan Kettering Cancer Center
2023

Institut de recherche mathématique de Rennes
2023

Universitat Autònoma de Barcelona
2000-2021

Parc de Salut
2012-2021

Municipal Institute for Medical Research
2005-2020

Hospital Universitari de Vic
1993-2019

Universitat de Barcelona
1997-2019

Nathaniel Rothman Montserrat García‐Closas Nilanjan Chatterjee Núria Malats Xifeng Wu and 95 more Jonine D. Figueroa Francisco X. Real David Van Den Berg Giuseppe Matullo Dalsu Baris Michael J. Thun Lambertus A. Kiemeney Paolo Vineis Immaculata De Vivo Demetrius Albanes Mark P. Purdue Þórunn Rafnar Michelle A.T. Hildebrandt Anne E. Kiltie Olivier Cussenot Klaus Golka Rajiv Kumar Jack A. Taylor José Mayordomo Kevin B. Jacobs Manolis Kogevinas Amy Hutchinson Zhaoming Wang Yi‐Ping Fu Ludmila Prokunina‐Olsson Laurie Burdett Meredith Yeager William Wheeler Adonina Tardón Consol Serra Alfredo Carrato Reina García-Closas Josep Lloreta Alison Johnson Molly Schwenn Margaret R. Karagas Alan R. Schned Gerald L. Andriole Robert L. Grubb Amanda Black Eric J. Jacobs W. Ryan Diver Susan M. Gapstur Stephanie J. Weinstein Jarmo Virtamo Victoria K. Cortessis Manuela Gago‐Dominguez Malcolm C. Pike Mariana C. Stern Jian‐Min Yuan David J. Hunter Monica McGrath Colin P. Dinney Bogdan Czerniak Meng Chen Hushan Yang Sita H. Vermeulen Katja K.H. Aben J.A. Witjes Remco R. Makkinje Patrick Sulem Søren Besenbacher Kári Stéfansson Elio Ríboli Paul Brennan Salvatore Panico Carmen Navarro Naomi E. Allen H. Bas Bueno-de-Mesquita Dimitrios Trichopoulos Neil E. Caporaso Maria Teresa Landi Federico Canzian Börje Ljungberg Anne Tjønneland Françoise Clavel‐Chapelon D. Timothy Bishop Mark Teo Margaret A. Knowles Simonetta Guarrera Silvia Polidoro Fulvio Ricceri Carlotta Sacerdote Alessandra Allione Géraldine Cancel‐Tassin Silvia Selinski Jan G. Hengstler H. Dietrich Tony Fletcher Péter Rudnai Eugen Gurzău Kvetoslava Koppová Sophia C.E. Bolick Ashley C. Godfrey Zongli Xu

10.1038/ng.687 article EN Nature Genetics 2010-10-24

The recently recognized Xp11 translocation renal cell carcinomas (RCCs), all of which bear gene fusions involving the TFE3 transcription factor gene, comprise at least one-third pediatric RCC. Only rare adult cases have been reported, without detailed pathologic analysis. We identified and analyzed 28 RCC in patients over age 20 years. All were confirmed by immunohistochemistry, a sensitive specific marker neoplasms with fusions, can be applied to archival material. Three also genetically....

10.1097/pas.0b013e318031ffff article EN The American Journal of Surgical Pathology 2007-07-23

Purpose To determine the frequency and prognostic value of fibroblast growth factor receptor 3 (FGFR3) mutations in patients with nonmuscle invasive bladder tumors according to tumor stage grade. Patients Methods Seven hundred seventy-two newly diagnosed were recruited. Tumors reviewed by expert pathologists. prospectively followed-up (median, 62.6 months for disease-free patients) through review hospital records telephone interviews. The sequence exons 7 10 FGFR3 was analyzed polymerase...

10.1200/jco.2005.05.1771 article EN Journal of Clinical Oncology 2006-07-28

Injury of the diaphragm may have clinical relevance having been reported in cases sudden infant death syndrome or fatal asthma. However, examination injury after acute inspiratory loading has not reported. The purpose this study was to determine whether an overload induces human and if from chronic obstructive pulmonary disease (COPD) is more susceptible injury. Eighteen patients with COPD 11 control normal function (62 +/- 10 yr) undergoing thoracotomy laparotomy were studied. A threshold...

10.1164/ajrccm.164.9.2011150 article EN American Journal of Respiratory and Critical Care Medicine 2001-11-01

Abstract We examined the effects of dose, type tobacco, cessation, inhalation, and environmental tobacco smoke exposure on bladder cancer risk among 1,219 patients with newly diagnosed 1,271 controls recruited from 18 hospitals in Spain. used unconditional logistic regression to estimate odds ratios (OR) 95% confidence intervals (95% CI) for association between various characteristics cigarette smoking. Current smokers (men: OR, 7.4; CI, 5.3-10.4; women: 5.1; 1.6-16.4) former 3.8; 2.8-5.3;...

10.1158/1055-9965.epi-06-0021 article EN Cancer Epidemiology Biomarkers & Prevention 2006-07-01
Jonine D. Figueroa Yuanqing Ye Afshan Siddiq Montserrat García‐Closas Nilanjan Chatterjee and 87 more Ludmila Prokunina‐Olsson Victoria K. Cortessis Charles Kooperberg Olivier Cussenot Simone Benhamou Jennifer Prescott Stefano Porru Colin P. Dinney Núria Malats Dalsu Baris Mark P. Purdue Eric J. Jacobs Demetrius Albanes Zhaoming Wang Xiang Deng Charles C. Chung Wei Tang H. Bas Bueno‐de‐Mesquita Dimitrios Trichopoulos Börje Ljungberg Françoise Clavel‐Chapelon Elisabete Weiderpass Vittorio Krogh Miren Dorronsoro Ruth C. Travis Anne Tjønneland Paul Brenan Jenny Chang‐Claude Elio Ríboli David V. Conti Manuela Gago‐Dominguez Mariana C. Stern Malcolm C. Pike David Van Den Berg Jian‐Min Yuan Chancellor Hohensee Rebecca J. Rodabough Géraldine Cancel‐Tassin Morgan Rouprêt Éva Compérat Constance Chen Immaculata De Vivo Edward Giovannucci David J. Hunter Peter Kraft Sara Lindström Angela Carta Sofia Pavanello Cecilia Arici Giuseppe Mastrangelo Ashish M. Kamat Seth P. Lerner H. Barton Grossman Jie Lin Jian Gu Xia Pu Amy Hutchinson Laurie Burdette William Wheeler Manolis Kogevinas Adonina Tardón Consol Serra Alfredo Carrato Reina García-Closas Josep Lloreta Molly Schwenn Margaret R. Karagas Alison Johnson Alan R. Schned Karla Armenti GM Monawar Hosain Gerald L. Andriole Robert L. Grubb Amanda Black W. Ryan Diver Susan M. Gapstur Stephanie J. Weinstein Jarmo Virtamo C.A. Haiman Maria Teresa Landi Neil E. Caporaso Joseph F. Fraumeni Paolo Vineis Xifeng Wu Debra T. Silverman Stephen J. Chanock Nathaniel Rothman

Candidate gene and genome-wide association studies (GWAS) have identified 11 independent susceptibility loci associated with bladder cancer risk. To discover additional risk variants, we conducted a new GWAS of 2422 cases 5751 controls, followed by meta-analysis two independently published GWAS, resulting in combined analysis 6911 814 controls European descent. TaqMan genotyping 13 promising single nucleotide polymorphisms P < 1 × 10−5 was pursued follow-up set 801 1307 controls. Two...

10.1093/hmg/ddt519 article EN public-domain Human Molecular Genetics 2013-10-24

Abstract Bladder cancer results from the combined effects of environmental and genetic factors, smoking being strongest risk factor. Evaluating absolute risks resulting joint factors is critical to assess public health relevance information. Analyses included up 3,942 cases 5,680 controls European background in seven studies. We tested for multiplicative additive interactions between 12 susceptibility loci, individually as a polygenic score (PRS). Thirty-year differences by levels PRS were...

10.1158/0008-5472.can-12-2388 article EN Cancer Research 2013-03-28

New, non-ablative methods can be used in skin rejuvenation. Histologic analysis of IPL effects on facial, sun-damaged skin.Five female subjects, wrinkle class I or II and Fitzpatrick types I, II, III. treatment: once monthly, 560-nm cut-off filters, spot size 8x35 mm, 28-36 J/cm. Routine histology electron microscopy 2-mm punches, before treatment then 1 week, 3 months, 12 months.Pre-treatment specimens contained solar elastosis perifollicular lymphoid infiltrates. Collagen elastic fibers...

10.1002/lsm.10042 article EN Lasers in Surgery and Medicine 2002-02-01

Abstract FGFR3 and Tp53 mutations have been proposed as defining two alternative pathways in the pathogenesis of transitional bladder cancer. are associated with low-grade tumors a favorable prognosis. alterations advanced and, possibly, poor We focus here on subgroup T1G3 superficial because they major clinical challenge. Patients (n = 119) were identified from prospective study 1,356 cases. Mutations (exons 7, 10, 15) 4-9) analyzed using PCR direct sequencing. All cases followed for...

10.1158/1078-0432.ccr-05-0122 article EN Clinical Cancer Research 2005-08-01

Genome-wide association studies have identified a SNP, rs2294008, on 8q24.3 within the prostate stem cell antigen ( PSCA ) gene, as risk factor for bladder cancer. To fine-map this region, we imputed 642 SNPs 100 Kb of rs2294008 in addition to 33 markers genotyped one reported genome-wide study 8,652 subjects. A multivariable logistic regression model adjusted revealed unique signal, rs2978974 r 2 = 0.02, D′ 0.19 with rs2294008). In combined analysis 5,393 cases and 7,324 controls, detected...

10.1073/pnas.1202189109 article EN Proceedings of the National Academy of Sciences 2012-03-13

Abstract High-grade T1 (HGT1) bladder cancer is the highest risk subtype of non–muscle-invasive with unpredictable outcome and poorly understood factors. Here, we examined association somatic mutation profiles nonrecurrent disease (GO, good outcome), recurrence (R), or progression (PD) in a cohort HGT1 patients. Exome sequencing was performed on 62 15 matched normal tissue samples. Both tumor only (TO) paired analyses were performed, focusing 95 genes known to be mutated cancer. Somatic...

10.1158/0008-5472.can-20-0977 article EN Cancer Research 2020-08-31

We attempted to determine the relationship between tumor volume and extent of localized prostate cancer, as well interrelationships with specific antigen (PSA) level, grade stage.Serial whole mount sections from 128 patients who underwent radical prostatectomy were analyzed using a computer assisted volumetric program. Statistical evaluations performed logistic simple regression analyses.The median for organ confined disease was significantly lower than those extraprostatic extension (1.25...

10.1016/s0022-5347(01)66790-9 article EN The Journal of Urology 1995-11-01

The clinical significance of intestinal spirochetosis is uncertain, therefore the aim present paper was to assess prevalence histological in patients with and without chronic watery diarrhea evaluate its relevance.A prospective diagnostic work-up made on biopsy samples taken from submitted between 1994 2004 (1174 colonoscopies multiple biopsies). Three other positive cases identified routine endoscopic biopsies also were reviewed. In addition, 100 asymptomatic control a random sample another...

10.1111/j.1440-1746.2006.04150.x article EN Journal of Gastroenterology and Hepatology 2006-03-23

Abstract BACKGROUND Although prostate cancer (PC) mortality disproportionately affects African‐American (AA) men, limited data exist comparing the pathologic characteristics of white and AA patients with nonpalpable PC (clinical stage T1c). METHODS The authors reviewed radical prostatectomy (RP) specimens from 37 consecutive men clinical T1c 35 who were matched for age, stage, serum prostate‐specific antigen (PSA) level, year surgery, weight, biopsy strategy. Pathologic compared after...

10.1002/cncr.21954 article EN Cancer 2006-05-30

Objectives: We investigated the association between occupation and bladder cancer in a hospital-based case–control study conducted Spain. Methods: 1219 patients with transitional cell carcinoma of urinary 1271 controls selected from 18 hospitals Spain June 1998 September 2000 provided detailed information on life-time occupational history, smoking habits, medical other factors. used unconditional logistic regression to calculate odds ratios (OR) 95% confidence intervals (CI) for each...

10.1136/oem.2007.035816 article EN Occupational and Environmental Medicine 2007-10-19
Coming Soon ...